v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2024 $ 281,238 $ 40 $ 903,127 $ 166 $ (622,095)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2024   40,428,220      
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount 697 $ 1 696    
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares   210,332      
Shares redeemed for employee tax withholdings, Amount (1,418)   (1,418)    
Shares redeemed for employee tax withholdings, Shares   (50,012)      
Stock-based compensation expense 7,140   7,140    
Unrealized loss on short-term investments and cash equivalents, net of tax (157)     (157)  
Foreign currency translation adjustment 6     6  
Net Income (Loss) (8,190)       (8,190)
Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2025 279,316 $ 41 909,545 15 (630,285)
Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2025   40,588,540      
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2024 281,238 $ 40 903,127 166 (622,095)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2024   40,428,220      
Unrealized loss on short-term investments and cash equivalents, net of tax (303)        
Net Income (Loss) (19,976)        
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2025 278,012 $ 41 920,159 (117) (642,071)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2025   40,913,380      
Stockholders' Equity, Beginning Balance, Amount at Mar. 31, 2025 279,316 $ 41 909,545 15 (630,285)
Stockholders' Equity, Beginning Balance, Shares at Mar. 31, 2025   40,588,540      
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount 1,362   1,362    
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares   268,485      
Stock-based compensation expense 8,547   8,547    
Shares issued for the employee stock purchase plan, Amount 705   705    
Shares issued for the employee stock purchase plan, Shares   56,355      
Unrealized loss on short-term investments and cash equivalents, net of tax (146)     (146)  
Foreign currency translation adjustment 14     14  
Net Income (Loss) (11,786)       (11,786)
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2025 278,012 $ 41 920,159 (117) (642,071)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2025   40,913,380      
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2025 $ 275,683 $ 41 936,628 53 (661,039)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2025 41,242,005 41,242,005      
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount $ 144 $ 0 144    
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares   204,323      
Shares redeemed for employee tax withholdings, Amount (473)   (473)    
Shares redeemed for employee tax withholdings, Shares   (62,208)      
Stock-based compensation expense 7,945   7,945    
Unrealized loss on short-term investments and cash equivalents, net of tax (120)     (120)  
Net Income (Loss) (15,884)       (15,884)
Stockholders' Equity, Ending Balance, Amount at Mar. 31, 2026 267,295 $ 41 944,244 67 (676,923)
Stockholders' Equity, Ending Balance, Shares at Mar. 31, 2026   41,384,120      
Stockholders' Equity, Beginning Balance, Amount at Dec. 31, 2025 $ 275,683 $ 41 936,628 53 (661,039)
Stockholders' Equity, Beginning Balance, Shares at Dec. 31, 2025 41,242,005 41,242,005      
Unrealized loss on short-term investments and cash equivalents, net of tax $ (125)        
Net Income (Loss) (27,981)        
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2026 $ 263,340 $ 41 952,378 (59) (689,020)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2026 41,585,381 41,585,381      
Stockholders' Equity, Beginning Balance, Amount at Mar. 31, 2026 $ 267,295 $ 41 944,244 67 (676,923)
Stockholders' Equity, Beginning Balance, Shares at Mar. 31, 2026   41,384,120      
Shares issued for the exercise of stock options and vesting of restricted stock units, Amount 52   52    
Shares issued for the exercise of stock options and vesting of restricted stock units, Shares   98,505      
Stock-based compensation expense 7,465   7,465    
Shares issued for the employee stock purchase plan, Amount 617   617    
Shares issued for the employee stock purchase plan, Shares   102,756      
Unrealized loss on short-term investments and cash equivalents, net of tax (5)     (5)  
Foreign currency translation adjustment 13     13  
Net Income (Loss) (12,097)       (12,097)
Stockholders' Equity, Ending Balance, Amount at Jun. 30, 2026 $ 263,340 $ 41 $ 952,378 $ (59) $ (689,020)
Stockholders' Equity, Ending Balance, Shares at Jun. 30, 2026 41,585,381 41,585,381